Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.24% | +0.87% | +20.34% |
May. 15 | Transcript : Merck & Co., Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 01:40 PM | |
May. 15 | Merck to present new oncology data | CF |
Financials (USD)
Sales 2024 * | 64.13B | Sales 2025 * | 68.6B | Capitalization | 332B |
---|---|---|---|---|---|
Net income 2024 * | 19.51B | Net income 2025 * | 22.25B | EV / Sales 2024 * | 5.48 x |
Net Debt 2024 * | 18.91B | Net Debt 2025 * | 7.65B | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
17
x | P/E ratio 2025 * |
14.7
x | Employees | 71,000 |
Yield 2024 * |
2.36% | Yield 2025 * |
2.49% | Free-Float | 70.77% |
Latest transcript on Merck & Co., Inc.
1 day | +0.24% | ||
1 week | +0.87% | ||
Current month | +1.52% | ||
1 month | +4.64% | ||
3 months | +2.66% | ||
6 months | +28.93% | ||
Current year | +20.34% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Davis
CEO | Chief Executive Officer | 57 | 14-03-31 |
Director of Finance/CFO | 55 | 89-12-31 | |
Dave Williams
CTO | Chief Tech/Sci/R&D Officer | 55 | 20-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Glocer
BRD | Director/Board Member | 63 | 07-11-26 |
Pamela Craig
BRD | Director/Board Member | 67 | 15-08-31 |
Inge Thulin
BRD | Director/Board Member | 69 | 18-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.34% | 254 M€ | +10.97% | - | |
5.61% | 17 M€ | +7.73% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 131.2 | +0.24% | 8,281,595 |
24-05-16 | 130.9 | -0.65% | 5,518,302 |
24-05-15 | 131.7 | +2.39% | 7,237,125 |
24-05-14 | 128.7 | -0.49% | 6,154,340 |
24-05-13 | 129.3 | -0.59% | 7,109,912 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.34% | 332B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B | |
-0.52% | 162B |
- Stock Market
- Equities
- MRK Stock